Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 790652, 9 pages
http://dx.doi.org/10.1155/2015/790652
Research Article

in Drinking Water Activated NF-κB Signal Pathway and Increased TGF-β and IL-1β Expressions in Bladder Epithelial Cells of Rats

Department of Environmental and Occupational Health, School of Public Health, China Medical University, No. 77 Puhe Road, Shenyang North New Area, Shenyang, Liaoning 110122, China

Received 1 September 2015; Accepted 19 October 2015

Academic Editor: Giuseppe Valacchi

Copyright © 2015 Siqi Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Dimethylarsinic acid () is the main product of arsenic methylation metabolism in vivo and is rat bladder carcinogen and tumor promoting agent. In this study, we measured the expressions of mRNA and proteins of NF-κB pathway members, IKKα, IKKβ, p65, and p50 in rat bladder epithelium by qRT-PCR and immunohistochemical analysis after rats received drinking water containing 100 and 200 ppm for 10 weeks. Transforming growth factor-β (TGF-β) immunoexpression in rat bladder epithelium and urine level of IL-1β also were determined. We found that dramatically increased the mRNA levels of NF-κB p50 and IKKα in the bladder epithelium of rats compared to the control group. Immunohistochemical examinations showed that increased immunoreactivities of IKKα, IKKβ, and phospho-NF-κB p50 in the cytoplasm and phospho-NF-κB p50 and p65 in nucleus of rat urothelial cells. In addition, treated rats exhibited significantly increased inflammatory factor TGF-β immunoreactivity in bladder epithelium and IL-1β secretion in urine. These data suggest that could activate NF-κB signal pathway and increase TGF-β and IL-1β expressions in bladder epithelial cells of rats.

1. Introduction

Dimethylarsinic acid () is the main product of arsenic methylation metabolism in vivo, excreted in urine. The animal experiment showed that rat exposure to suffered from bladder toxicity, especially urothelial tumors [13].   is considered to be the rat bladder carcinogen and tumor promoting agent [4]. The mechanism of induced cancer may be related to proliferation, apoptosis, oxidative stress, and inflammatory reaction. Our previous study showed that increased the expressions of proliferation factors in bladder urothelium and elevated transforming growth factor-beta 1 (TGF-β1) secretion and decreased tumor necrosis factor-alpha (TNF-α) level in the urine of rats [5]. Our and other studies suggested that chronic inflammation, bladder epithelium lesions, and proliferation might be the basic process of the chronic toxicity effects of on rats.

It was reported that nuclear factor-kappa B (NF-κB) nuclear expression is correlated with histologic grade and T category in bladder urothelium cancer [6]. NF-κB is a heterodimeric, sequence-specific transcription factor and consists of two major subunit polypeptides, p50 and p65. In unstimulated cells, NF-κB is in the cytoplasm bound to the inhibitor-kappa B (IκB) as an inactive cytoplasmic precursor [7]. Extracellular stimuli could activate IκB kinase (IKK), which leads to IκB phosphorylation and degradation [8]. Subsequently, NF-κB is liberated and translocates into the nucleus, where it actively regulates the transcription of a wide variety of reporter genes [9]. NF-κB is thought to be a critical mediator of physiological and pathological processes including cell survival, proliferation, apoptosis, tumorigenesis, and inflammation [10]. NF-κB has been reported to link inflammation with tumor progression and plays a functional role in inflammation and tumorigenesis [11]. NF-κB is activated by a variety of stimuli including growth factors, cytokines, inflammatory agents, pharmacological agents, carcinogens, and stress.

Immunohistochemical analysis of urinary bladder tumor samples from 140 patients showed a strong correlation between cyclooxygenase 2 (COX-2) and nuclear NF-κB immunoreactivity [12]. COX-2 is NF-κB target gene [10]. In our previous study, COX-2 expression in bladder urothelium increased in treated rats. Despite the critical importance of NF-κB in cancer, the function of NF-κB in urothelium of treated rats remains poorly defined. In the present study, NF-κB signal pathways in bladder epithelial cells of subchronic exposure to rats were investigated to focus on the effects of on NF-κB signal pathways. In addition, inflammatory factors expressions in urothelium and secretion in urine of rats were also analyzed.

2. Materials and Methods

2.1. Chemicals

(purity 99%) was purchased from Sangon Biotech (Shanghai, China). Trizol solution was from Invitrogen (Carlsbad, CA, USA). Real-Time PCR test kits were purchased from TaKara Biotechnology (Dalian, China). Polyclonal antibodies against IKKα, IKKβ, phospho-p65, phospho-p50, and TGF-β were obtained from Sangon Biotech Co., Ltd. (Shanghai, China). IL-1β ELISA kits were obtained from Dakewe Bio-Engineering Limited Company (Shenzhen, China). All chemicals used in the study were of analytical grade.

2.2. Animals and Treatment

60 female healthy weanling SPF-grade Wistar rats (40–50 g) were obtained from Experimental Animal Center of China Medical University (China). After rats were acclimatized to the environmental conditions for one week, they were randomly selected into three groups consisting 20 rats per group. Group I includes control rats receiving distilled water as drinking water. Group II includes experimental rats receiving drinking water containing 100 ppm . Group III includes experimental rats receiving drinking water containing 200 ppm . The rats had free access to the standard rodent diet supplied by Experimental Animal Center of China Medical University and drinking water ad libitum. During the course of treatment, rats were observed daily for clinical signs, and daily water consumption and body weight gain were recorded periodically. All of the rats were kept in ventilated cages at 23–27°C, with 55–60% humidity and 12/12 h light/dark cycles. At last exposure week, 10 rats per group were placed in metabolic cages and 24 h urine samples were collected and frozen at −80°C until analyzed. After 10 weeks, exposure was stopped and rats were sacrificed under 10% chloral hydrate anesthesia. Within two minutes of the death of the rat, the bladders of 30 rats (10 rats each group) were ligated, rinsed, and then filled with cold Trizol solution for ten minutes. The cell lysate, containing urinary bladder urothelial cells, was aspirated for RNA extraction. The other bladders were fixed in 10% buffered paraformaldehyde and were cut longitudinally into strips, routinely embedded in paraffin for immunohistochemical analysis. The experimental procedure used in this study met the guidelines of the Animal Care and Use Committee of the China Medical University.

2.3. Quantitative Reverse Transcription-PCR (qRT-PCR) Analysis

Total RNA was extracted from the Trizol reagent of bladder epithelia according to the supplier’s recommendations. The purity of each RNA sample was assessed by measuring absorbance at 260 and 280 nm and calculating the ratio. cDNA was synthesized using a reverse transcription reaction by the Easy RT-PCR kit according to the manufacturer’s protocol. qRT-PCR reactions were performed using ABI 7500 real-time detection system (Applied Biosystems, Foster City, CA, USA) to determine the levels of mRNA. The primers for IKKα, IKKβ, p65, p50, and IκBα genes were synthesized by Sangon Biotech (Shanghai, China), and primer sequences are listed in Table 1. Thermocycling was performed in a final volume of 25 μL containing 5 μL of cDNA sample, 2 μL of the primers, and 18 μL of SYBR green PCR master mix (TaKara Biotechnology, Dalian, China). Fold changes for each gene expression were calculated using the Delta Ct method normalizing to β-actin expression for each sample.

Table 1: The sense and antisense primers used for qRT-PCR.
2.4. Immunohistochemical Analysis

The bladder tissues in 10% paraformaldehyde were embedded in paraffin and then cut into 5 μm sections on glass slides. Sections were deparaffinized, rehydrated, and subjected to a sequence of incubation steps starting with blocking endogenous peroxidase with 3% hydrogen peroxide at room temperature for 10 min. After microwave irradiation in 0.1 M PBS buffer for 10 minutes for epitope recovery, blocking buffer (5% bovine serum albumin, BSA) was added to each section and incubated at room temperature for 20 min. Then sections were incubated with polyclonal antibodies against IKKα, IKKβ, p-p65, p-p50, and TGF-β in a humidity chamber at 37°C for 30 min. Subsequently, the slides were rinsed with PBS and incubated with secondary antibodies containing horseradish peroxidase at 37°C for 30 min. The slides were then washed in PBS and incubated with SABC reagent at 37°C for 30 min. After this treatment, the slides were stained with 3.3′-diaminobenzidine tetrahydrochloride (DAB) and then counterstained with hematoxylin. The immunohistochemical stainings were viewed and captured with a light microscope (Olympus bx51, Japan) at 200 or 400x magnification. The immunointensities of IKKα, IKKβ, phospho-p65, phospho-p50, and TGF-β were measured with an image analyzer (Meta Morph, UIC, USA) by measuring the integrated optical density average (IOD) at five randomly selected fields. The positive rates of phospho-p65 and phospho-p50 expressions in nuclei were calculated by dividing the number of positive nuclei by the total number of nuclei counted, and the results were expressed as percentages (%).

2.5. ELISA Test

IL-1β in urine was measured using an ELISA kit according to the instructions of the manufacturer. The concentration of IL-1β was calculated according to the standard curve of the ELISA kits and expressed as pg/mL.

2.6. Statistical Analysis

Data were analyzed with SPSS for Windows, version 13.0. Differences between groups were statistically analyzed by LSD or Dunnett’s T3 after one-way analysis of variance (ANOVA). The results were expressed as mean ± SD of number of experiments. value < 0.05 was designated as statistically significant.

3. Results

3.1. General Observation

All rats were observed once daily with detailed evaluation during the study period. Administration of (100 and 200 ppm) did not disturb food intake and body weight gain (Figure 1(a)). There was a little decrease of water consumption in 100 and 200 ppm treated rats at 9th and 10th weeks as compared with control rats, but there were no significant differences in water consumption between the groups (Figure 1(b)).

Figure 1: Body weight and real amount of drinking water of rats. The linear charts represent (a) body weight (g) and (b) amount of drinking water (mL) of rats after being exposed to 100 or 200 ppm in drinking water from the first week to tenth week.
3.2. mRNA Expressions of NF-κB Signaling Molecules in the Bladder Epithelium of Rats Exposed to

The effect of on the mRNA expressions of NF-κB signaling molecules in the bladder epithelium of rats was depicted in Figure 2. The treatment with 100 and 200 ppm for 10 weeks dramatically increased the mRNA levels of NF-κB p50 and IKKα in the bladder epithelium of rats compared to the control group (). Although there was a dose-dependent increase tendency for IKKβ mRNA expression, there were no statistical differences between treated rats and control rats. Significant changes for NF-κB p65 and IkBα mRNA expressions were not seen.

Figure 2: Effects of on the mRNA expressions of IKKα, IKKβ, p65, p50, and IκBα of bladder epithelium in rats. IKKα, IKKβ, p65, p50, and IκBα mRNA levels of bladder epithelium in rats were measured by qRT-PCR. Bars were presented as mean ± SD. compared to the control group.
3.3. Immunoreactivities for NF-κB Signaling Molecules in the Bladder Epithelium of Rats Exposed to

Immunohistochemical examinations revealed that 100 or 200 ppm administration caused significant increase in the immunoreactivities of IKKα and IKKβ in the cytoplasm of rat urothelial cells (Figures 3 and 4). Immunoreactivities of phospho-NF-κB p50 in nucleus and cytoplasm displayed significant increase in treated rat bladder epithelium (Figure 5). Nuclear phospho-NF-κB p65 immunoexpression increased in 100 and 200 ppm treated rat bladder epithelium and levels of phospho-NF-κB p65 immunoexpression in cytoplasm did not increase in treated rats compared with control rats (Figure 6).

Figure 3: IKKα immunohistochemical staining of bladder epithelium in treated rats. IKKα expressions were presented in brown in cytoplasm. The panel was a graphical representation of the immunointensities of IKKα. Bars were presented as mean ± SD. compared to the control group.
Figure 4: IKKβ immunohistochemical staining of bladder epithelium in treated rats. IKKβ expressions were presented in brown in cytoplasm. The panel was a graphical representation of the immunointensities of IKKβ. Bars were presented as mean ± SD. compared to the control group.
Figure 5: p50 immunohistochemical staining of bladder epithelium in treated rats. p50 expressions were presented in brown in cytoplasm and nucleus. The panel was a graphical representation of the immunohistochemical staining of p50. Bars were presented as mean ± SD. and compared to the control group. compared to 100 ppm treated group.
Figure 6: p65 immunohistochemical staining of bladder epithelium in treated rats. p65 expressions were presented in brown in cytoplasm and nucleus. The panel was a graphical representation of the immunohistochemical staining of p65. Bars were presented as mean ± SD. and compared to the control group.
3.4. Increased TGF-β Expression in the Bladder Epithelium and Promoted Urinary IL-1β Secretion in Rats

In our previous study, 200 ppm treated rats exhibited significantly increased inflammatory factor TGF-β1 level in urine compared to the control rats [5]. In the present immunohistochemical localization analysis, TGF-β expression was elevated in 100 and 200 ppm treated rat bladder epithelium. In addition, 200 ppm treatment also increased IL-1β secretion in urine of rats. These data suggest that stimulates the production of proinflammatory cytokines in rat bladder; see Figure 7.

Figure 7: TGF-β immunohistochemical staining of bladder epithelium and urinary IL-1β levels in treated rats. TGF-β expressions were presented in brown in cytoplasm. The panel was a graphical representation of the immunointensities of TGF-β. The concentrations of IL-1β in urine were measured by ELISA kits and bars were presented as mean ± SD. and compared to the control group.

4. Discussion

Inorganic arsenic is a known human carcinogen and undergoes metabolic methylation in mammals and is metabolized to . However, has been demonstrated to be a bladder carcinogen in rats [3, 13] and also enhanced bladder carcinogenesis when administered in the drinking water after treatment with N-butyl-N-(4-hydroxybutyl) nitrosamine, a known bladder carcinogen [14]. Inorganic arsenic likely has multiple mechanisms of carcinogenic action [4] and dysregulates some signal pathways through transcriptional and nongenomic mechanisms [1517]. Few studies were reported on molecular mechanisms of carcinogenesis. The transcriptional factor NF-κB is activated in a range of human cancers and promotes tumorigenesis via regulation of target gene expression [18, 19]. NF-κB is widely considered to play a major role in tumor development by promoting cell survival, proliferation, angiogenesis, and metastasis [10, 19]. It has been demonstrated that inorganic arsenic could activate NF-κB signaling pathway [20, 21]. The effects of on NF-κB signaling pathway in bladder cells remain unclear. In the present study, we observed that expressions of members of the NF-κB signaling pathway and IKKα, IKKβ, p50, and p65 were increased in bladder epithelium of rats after exposure to .

NF-κB activation was attributed to the phosphorylation of IκB protein by IKK kinase. The activation of IKK kinase results in IκB polyubiquitination and subsequent degradation by the 26S proteasome [22]. After that, the NF-κB p50 and p65 subunits in cytoplasm activate and subsequently translocate into nucleus. Our study showed that 100 and 200 ppm treatment in drinking water significantly increased IKKα and IKKβ mRNA levels and protein expressions in bladder epithelium of rats, which indicated activated IKK kinase. In exposure rat bladder epithelium, NF-κB immunolocalization displayed the fact that p65 protein expression increased in the nucleus, whereas cytoplasmic p65 immunoexpression did not increase. p50 protein expression increased in both the nucleus and cytoplasm in exposure rat bladder epithelium. Generally, nuclear immunoreactivity is regarded as a surrogate marker for the activated NF-κB protein. The urothelial lining of the bladder is a responsive epithelial tissue with the ability to react to a variety of stimuli [23]. Thus, we thought that led to the activation of the NF-κB pathway in rat bladder epithelium.

NF-κB was initially characterized as a central regulator in inflammatory and immune responses. It could connect chronic inflammation and tumorigenesis and was a potential molecular bridge between inflammation and cancer [24, 25]. NF-κB is induced by various cell stresses including growth factors, cytokines, and oxidative stress [26] and in turn regulates numbers of genes encoding proteins involved in immune and inflammatory responses, such as cytokines, growth factors, immune receptors [27]. Inflammation has been thought to contribute to the development of cancer. Within the tumor microenvironment, certain inflammatory mediators often play a fundamental role in regulating tumor subpopulation expression [28]. Proinflammatory cytokines, IL-1β and IL-8, regulated by NF-κB caused inflammatory responses and were critical components in the tumorigenesis pathway [28]. IL-1β was activated and amplified by NF-κB via a positive amplifying loop [29, 30]. It has been reported that activated NF-κB in cancer stem cells (CSCs) can promote a proinflammatory environment, inhibit apoptosis, and stimulate cell proliferation [31, 32]. Active NF-κB translocates to the nucleus and binds to target proinflammatory genes, inducing transcription of cytokines, including IL-1β [33]. On the other hand, cytokines released from the tumor microenvironment could elevate NF-κB activity [34]. TGF-β activated kinase, TAK1, was shown to mediate responses to cytokines TNF-α or IL-1 and directly phosphorylate the IKK complex that promotes activation of NF-κB [3537]. TGF-β induces NF-κB activation through phosphorylation and activation of TAK1 in head and neck squamous cell carcinoma. TAK1, as an upstream mediator of IKKα/β phosphorylation and activation, leads to phosphorylation and degradation of the NF-κB inhibitor IκBα and induces nuclear translocation and transactivation of NF-κB [38]. In the present study, we observed that increased TGF-β expression in bladder epithelium and IL-1β secretion in urine of rats. It is widely accepted that TGF-β and IL-1 are powerful signaling molecules and involve many cellular processes, and their altered expression profiles are associated with various pathologies [39]. Overexpression of TGF-β in the tumor microenvironment was often observed [40] and TGF-β was one of the key growth factors involved in driving epithelial-mesenchymal transition (EMT) [41]. IL-1β both induced inflammation by activating NF-κB signaling [37] and also was controlled by NF-κB signaling [42].

Our precious study found DMA elevated expressions of proliferation factors, such as PCNA, cyclin D1, and COX-2, in bladder epithelium [5]. The possible mechanism of on bladder epithelium in this study was speculated because activated NF-κB signal pathway, which increased the secretion of TGF-β and IL-1β in rats. Furthermore, increased expressions of TGF-β and IL-1β might mediate activation of NF-κB signal pathway to promote cell proliferation.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgment

This work was supported by the National Natural Science Foundation of China (NSFC) (81072244 and 81373023).

References

  1. S. Yamamoto, Y. Konishi, T. Matsuda et al., “Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens,” Cancer Research, vol. 55, no. 6, pp. 1271–1276, 1995. View at Google Scholar · View at Scopus
  2. M. Wei, H. Wanibuchi, K. Morimura et al., “Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors,” Carcinogenesis, vol. 23, no. 8, pp. 1387–1397, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. L. L. Arnold, M. Eldan, A. Nyska, M. van Gemert, and S. M. Cohen, “Dimethylarsinic acid: results of chronic toxicity/oncogenicity studies in F344 rats and in B6C3F1 mice,” Toxicology, vol. 223, no. 1-2, pp. 82–100, 2006. View at Publisher · View at Google Scholar
  4. International Agency for Research on Cancer (IARC), “Arsenic in drinking water,” in Some Drinking Water Disinfectants and Contaminants, Including Arsenic, vol. 84 of Monographs on the Evaluation of Carcinogenic Risk to Humans, pp. 269–477, International Agency for Research on Cancer, 2004. View at Google Scholar
  5. Z. Lin, L. Shengnan, W. Fei et al., “Dimethylarsinic acid (DMAV) changed the expressions of proliferative related factors and secretion of inflammatory cytokines in rat bladder,” Journal of Applied Toxicology, vol. 35, no. 2, pp. 133–141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Levidou, A. A. Saetta, P. Korkolopoulou et al., “Clinical significance of nuclear factor (NF)-κB levels in urothelial carcinoma of the urinary bladder,” Virchows Archiv, vol. 452, no. 3, pp. 295–304, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. S. Baldwin Jr., “The NF-kappa B and I kappa B proteins: new discoveries and insights,” Annual Review of Immunology, vol. 14, pp. 649–683, 1996. View at Google Scholar
  8. M. J. May and S. Ghosh, “IκB kinases: kinsmen with different crafts,” Science, vol. 284, no. 5412, pp. 271–273, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Dejardin, V. Deregowski, M. Chapelier et al., “Regulation of NF-κB activity by IκB-related proteins in adenocarcinoma cells,” Oncogene, vol. 18, no. 16, pp. 2567–2577, 1999. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Karin, Y. Cao, F. R. Greten, and Z.-W. Li, “NF-kappaB in cancer: from innocent bystander to major culprit,” Nature Reviews Cancer, vol. 2, no. 4, pp. 301–310, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. F. R. Greten, L. Eckmann, T. F. Greten et al., “IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer,” Cell, vol. 118, no. 3, pp. 285–296, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Kontos, G. Sotiropoulou-Bonikou, A. Kominea, M. Melachrinou, E. Balampani, and D. Bonikos, “Coordinated increased expression of cyclooxygenase2 and nuclear factor κB is a steady feature of urinary bladder carcinogenesis,” Advances in Urology, vol. 2010, Article ID 871356, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Wei, H. Wanibuchi, S. Yamamoto, W. Li, and S. Fukushima, “Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats,” Carcinogenesis, vol. 20, no. 9, pp. 1873–1876, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Wanibuchi, S. Yamamoto, H. Chen et al., “Promoting effects of dimethylarsinic acid on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats,” Carcinogenesis, vol. 17, no. 11, pp. 2435–2439, 1996. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Liu, F. Wang, L. Yan et al., “Oxidative stress and MAPK involved into ATF2 expression in immortalized human urothelial cells treated by arsenic,” Archives of Toxicology, vol. 87, no. 6, pp. 981–989, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Wang, S. Liu, S. Xi et al., “Arsenic induces the expressions of angiogenesis-related factors through PI3K and MAPK pathways in SV-HUC-1 human uroepithelial cells,” Toxicology Letters, vol. 222, no. 3, pp. 303–311, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. G. J. Ahlborn, G. M. Nelson, W. O. Ward et al., “Dose response evaluation of gene expression profiles in the skin of K6/ODC mice exposed to sodium arsenite,” Toxicology and Applied Pharmacology, vol. 227, no. 3, pp. 400–416, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. T. D. Gilmore, “Introduction to NF-κB: players, pathways, perspectives,” Oncogene, vol. 25, no. 51, pp. 6680–6684, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. M. Chaturvedi, B. Sung, V. R. Yadav, R. Kannappan, and B. B. Aggarwal, “NF-κB addiction and its role in cancer: ‘one size does not fit all’,” Oncogene, vol. 30, no. 14, pp. 1615–1630, 2011. View at Publisher · View at Google Scholar
  20. S. Huang, S. Guo, F. Guo et al., “CD44v6 expression in human skin keratinocytes as a possible mechanism for carcinogenesis associated with chronic arsenic exposure,” European Journal of Histochemistry, vol. 57, no. 1, article e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Jiang, Y. Li, Y. Xu et al., “EMT and CSC-like properties mediated by the IKKβ/IκBα/RelA signal pathway via the transcriptional regulator, Snail, are involved in the arsenite-induced neoplastic transformation of human keratinocytes,” Archives of Toxicology, vol. 87, no. 6, pp. 991–1000, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Y.-C. Hseu, K. J. Senthil Kumar, C.-S. Chen et al., “Humic acid in drinking well water induces inflammation through reactive oxygen species generation and activation of nuclear factor-κB/activator protein-1 signaling pathways: a possible role in atherosclerosis,” Toxicology and Applied Pharmacology, vol. 274, no. 2, pp. 249–262, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. L. E. Olsson, M. A. Wheeler, W. C. Sessa, and R. M. Weiss, “Bladder instillation and intraperitoneal injection of Escherichia coli lipopolysaccharide up-regulate cytokines and iNOS in rat urinary bladder,” Journal of Pharmacology and Experimental Therapeutics, vol. 284, no. 3, pp. 1203–1208, 1998. View at Google Scholar · View at Scopus
  24. S. Holdenrieder and P. Stieber, “Apoptotic markers in cancer,” Clinical Biochemistry, vol. 37, no. 7, pp. 605–617, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Celec, “Nuclear factor κ B-molecular biomedicine: the next generation,” Biomedicine and Pharmacotherapy, vol. 58, no. 6-7, pp. 365–371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Karin and F. R. Greten, “NF-kappaB: linking inflammation and immunity to cancer development and progression,” Nature Reviews Immunology, vol. 5, no. 10, pp. 749–759, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. U. Rehman, M. Tahir, A. Q. Khan et al., “Chrysin suppresses renal carcinogenesis via amelioration of hyperproliferation, oxidative stress and inflammation: plausible role of NF-κB,” Toxicology Letters, vol. 216, no. 2-3, pp. 146–158, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Y. W. Bourguignon, G. Wong, C. A. Earle, and W. Xia, “Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion,” Cytoskeleton, vol. 68, no. 12, pp. 671–693, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Ruiz-Deya, S. C. Sikka, R. Thomas, and A. B. Abdel-Mageed, “Potential role for the nuclear transcription factor NF-κB in the pathogenesis of ureteropelvic junction obstruction,” Journal of Endourology, vol. 16, no. 8, pp. 611–615, 2002. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Zhu, L. Zhang, S. Ling et al., “Scropolioside B inhibits IL-1β and cytokines expression through NF-κB and inflammasome NLRP3 pathways,” Mediators of Inflammation, vol. 2014, Article ID 819053, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Chefetz, J. C. Holmberg, A. B. Alvero, I. Visintin, and G. Mor, “Inhibition of Aurora-a kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFκB pathway,” Cell Cycle, vol. 10, no. 13, pp. 2206–2214, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. A. B. Alvero, R. Chen, H.-H. Fu et al., “Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance,” Cell Cycle, vol. 8, no. 1, pp. 158–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. X.-C. Wang, R. Saban, J. H. Kaysen et al., “Nuclear factor kappa B mediates lipopolysaccharide-induced inflammation in the urinary bladder,” Journal of Urology, vol. 163, no. 3, pp. 993–998, 2000. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. Ben-Neriah and M. Karin, “Inflammation meets cancer, with NF-κB as the matchmaker,” Nature Immunology, vol. 12, no. 8, pp. 715–723, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. D. G. Jackson-Bernitsas, H. Ichikawa, Y. Takada et al., “Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-κB activation and proliferation in human head and neck squamous cell carcinoma,” Oncogene, vol. 26, no. 10, pp. 1385–1397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Sakurai, H. Miyoshi, W. Toriumi, and T. Sugita, “Functional interactions of transforming growth factor β-activated kinase 1 with IκB kinases to stimulate NF-κB activation,” Journal of Biological Chemistry, vol. 274, no. 15, pp. 10641–10648, 1999. View at Publisher · View at Google Scholar · View at Scopus
  37. G. Takaesu, S. Kishida, A. Hiyama et al., “TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway,” Molecular Cell, vol. 5, no. 4, pp. 649–658, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Freudlsperger, Y. Bian, S. Contag Wise et al., “TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers,” Oncogene, vol. 32, no. 12, pp. 1549–1559, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. G. M. Gordon, D. R. Ledee, W. J. Feuer, and M. E. Fini, “Cytokines and signaling pathways regulating matrix metalloproteinase-9 (MMP-9) expression in corneal epithelial cellsy,” Journal of Cellular Physiology, vol. 221, no. 2, pp. 402–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. W. Cui, D. J. Fowlis, S. Bryson et al., “TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice,” Cell, vol. 86, no. 4, pp. 531–542, 1996. View at Publisher · View at Google Scholar · View at Scopus
  41. H. Kim, J.-A. Choi, and J.-H. Kim, “Ras promotes transforming growth factor-β(TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells,” The Journal of Biological Chemistry, vol. 289, no. 32, pp. 22151–22160, 2014. View at Publisher · View at Google Scholar · View at Scopus
  42. M. C. Catley, J. E. Chivers, L. M. Cambridge et al., “IL-1beta dependent activation of NF-kappaB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase,” FEBS Letters, vol. 547, no. 1–3, pp. 75–79, 2003. View at Publisher · View at Google Scholar · View at Scopus